|  | Vitamin D (N = 42) | Placebo (N = 43) | crude P-value* | Adjusted P-value*** |
---|---|---|---|---|---|
VitaminD (ng/ml) | Baseline | 17.24 (7.83) | 17.56 (7.82) | 0.853 | < 0.001 |
After intervention | 38.86 (10.76) | 14.79 (7.08) | < 0.001 | ||
P-value** | < 0.001 | < 0.001 |  | ||
HbA1c (%) | Baseline | 7.51 (0.87) | 7.15 (1.12) | 0.103 | < 0.001 |
After intervention | 6.76 (0.98) | 7.21 (1.11) | 0.051 | ||
P-value** | < 0.001 | 0.657 |  | ||
SIRT1 (ng/ml) | Baseline | 24.94 (4.38) | 25.57 (3.37) | 0.455 | < 0.001 |
After intervention | 27.90 (5.58) | 23.40 (3.88) | < 0.001 | ||
P-value** | < 0.001 | < 0.001 |  | ||
Irisin (ng/ml) | Baseline | 18.15 (5.96) | 20.13 (7.17) | 0.171 | Â |
After intervention | 21.99 (5.93) | 14.98 (2.76) | < 0.001 | < 0.001 | |
P-value** | < 0.001 | < 0.001 |  | ||
HOMA-IR (N) | Baseline | 5.36 (3.23) | 5.83 (3.09) | 0.499 | 0.421 |
After intervention | 6.44 (3.73) | 7.39 (4.58) | 0.295 | ||
P-value** | 0.006 | 0.003 | Â | ||
QUICKI (N) | Baseline | 0.76 (0.08) | 0.73 (0.06) | 0.149 | 0.645 |
After intervention | 0.73 (0.07) | 0.71 (0.07) | 0.217 | ||
P-value** | 0.005 | 0.003 | Â |